Calcium hasco (raspberry flavored)

Package leaflet: Information for the user

CALCIUM HASCO
115.6 mg calcium ions / 5 ml, syrup
Calcii glubionas anhydricus + Calcii lactobionas dihydricus
Raspberry-flavoured syrup
Please read all of this leaflet carefully before taking this medicine, because it contains
important information for the patient.
This medicine should always be taken exactly as described in this patient leaflet or as directed by
the doctor or pharmacist.

• Keep this leaflet, so that you can read it again if necessary.
• If you need advice or further information, please consult your pharmacist.
• If you experience any adverse reactions, including any not listed in this leaflet, tell your doctor or pharmacist. See section 4.
• If you do not get better or if you feel worse, you should contact your doctor.

Contents of the leaflet

1. What Calcium Hasco is and what it is used for
2. Important information before taking Calcium Hasco
3. How to take Calcium Hasco
4. Possible side effects
5. How to store Calcium Hasco
6. Contents of the package and other information

1. What Calcium Hasco is and what it is used for

Calcium Hasco is a medicinal product containing calcium salts. Calcium is a structural component of the body and plays an important role in many physiological processes (maintenance of normal blood coagulation, muscle contractility, nerve conduction, cellular membrane function). Calcium also reduces the permeability of blood vessel walls, exerting anti-exudative and anti-edematous effects. Calcium crosses the placenta and is excreted in breast milk.
Indications:

• Prevention and supplementation of calcium deficiency in the body, e.g. during pregnancy or breastfeeding,
• Treatment of osteoporosis,
• Adjunctive treatment of allergy symptoms.

2. Important information before using Calcium Hasco

When not to use Calcium Hasco

• if the patient is allergic to the active substances (calcium salts) or to any of the other ingredients of this medicine (listed in section 6);
• if the patient has elevated calcium levels in the blood (hypercalcaemia, e.g. in patients with hyperparathyroidism, severe renal insufficiency, or vitamin D overdose);
• if the patient has increased calcium excretion in urine (hypercalciuria);
• if the patient has severe renal insufficiency or kidney stones (nephrolithiasis);
• if the patient has atrioventricular block.

1/4
Warnings and precautions
Before starting treatment with Calcium Hasco, please consult a doctor or pharmacist.
Special caution is required when using Calcium Hasco:

• if the patient has renal insufficiency;
• if the patient is taking high doses of vitamin D.

Calcium Hasco and other medicines
Inform your doctor or pharmacist about all medicines currently used, recently used, or planned to be used.
High doses of calcium taken concomitantly with certain cardiac medications (digitalis glycosides or calcium channel blockers) may cause serious disturbances in heart function.
Calcium significantly reduces the absorption of certain antibiotics (tetracyclines and quinolones), levothyroxine, nitrofurantoin, bisphosphonates, chlorpromazine, penicillamine, anticoagulants, and fluoride compounds. Therefore, it is recommended that the interval between taking Calcium Hasco syrup and these medicines be about 3 hours.
Diuretics of the thiazide group reduce calcium excretion, while vitamin D increases calcium absorption.

Pregnancy and breastfeeding
If the patient is pregnant, breastfeeding, suspects she may be pregnant, or is planning to have a child, she should consult a doctor or pharmacist before using this medicine.

Driving and operating machinery
This medicine has no effect on the ability to drive or operate machinery.

Calcium Hasco contains sucrose, sodium benzoate (E 211), propylene glycol (E 1520), and sodium

Sucrose
The medicine contains 1.5 g of sucrose in each 5 ml of syrup. This should be taken into account in patients with diabetes. If the patient has previously been diagnosed with intolerance to certain sugars, the patient should contact a doctor before taking this medicine.

Sodium benzoate (E 211)
The medicine contains 10 mg of sodium benzoate in each 5 ml of syrup. Sodium benzoate may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of age).

Propylene glycol (E 1520)
The medicine contains approximately 2.43 mg of propylene glycol in each 5 ml of syrup. Before administering this medicine to a child under 4 weeks of age, consult a doctor or pharmacist, especially if the child is taking other medicines containing propylene glycol or alcohol.

Sodium
The medicine contains less than 1 mmol (23 mg) of sodium per 5 ml of syrup, meaning the medicine is considered "sodium-free".

3. How to use Calcium Hasco

This medicine should always be used exactly as described in this patient information leaflet, or as directed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
The medicine is taken orally.
2/4
Adults: 15 ml, 2 or 3 times daily.
Children: up to 6 years: 5 ml, 2 or 3 times daily,
from 6 to 12 years: 10 ml, 2 or 3 times daily.
The medicine should be measured using the provided measuring device.
If you feel that the effect of Calcium Hasco is too strong or too weak, consult your doctor or pharmacist.
Taking more than the recommended dose of Calcium Hasco
Cases of overdose with Calcium Hasco have not been reported. If you take more than the recommended dose, seek medical advice immediately.
Missing a dose of Calcium Hasco
Do not take a double dose to make up for a missed dose.
If you have any further questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible adverse reactions

Like all medicines, this medicine can cause adverse reactions, although not everybody will experience them.
Uncommon adverse reactions (in 1 to 10 patients out of 10,000):

• gastrointestinal disturbances (constipation, diarrhoea),
• in patients with impaired kidney function, oral administration of high doses of calcium may lead to hypercalcaemia, the symptoms of which include: nausea, abdominal pain, bone pain and muscle weakness.

Reporting of adverse reactions
If any adverse reactions occur, including any adverse reactions not listed in this leaflet, inform your doctor or pharmacist. Adverse reactions can be reported directly to the Department for Monitoring Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the marketing authorization holder.
Reporting adverse reactions helps to provide more information on the safety of the medicine.

5. How to store Calcium Hasco

Store below 25°C. Keep in the original packaging.
The medicine should be stored out of sight and reach of children.
Shelf life after first opening – 6 months.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the stated month.
3/4
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What Calcium Hasco contains

• The active substances are organic calcium salts (anhydrous calcium gluconolactobionate and dihydrate calcium lactobionate) in an amount equivalent to 115.6 mg of calcium ions in 5 ml of syrup.
• The other ingredients (excipients) are: sucrose, sodium benzoate (E 211), monohydrate citric acid (E 330), raspberry flavour (containing propylene glycol (E 1520)), purified water.

What Calcium Hasco looks like and contents of the pack
Calcium Hasco is a yellowish syrup.
One pack (a brown glass bottle) contains 150 ml of solution.
The bottle with the dosing cup is placed in a cardboard box.
Marketing Authorisation Holder and Manufacturer
„PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK” S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
Medicinal product information
tel.: (22) 742 00 22
e-mail: [email protected]
4/4